From High-Throughput to Point-of-Care Oncology Testing: Cutting-Edge Genotyping Chemistries for Direct Analysis of Blood, FFPE Tissue, Urine and Stool
Wednesday, November 15, 2023
9:00 AM – 9:50 AM MST
In this session, we will look at PCR genotyping technology and the latest chemistries that Meridian developed for the identification of mutations, including single nucleotide polymorphisms (SNPs). Lyo-Ready™ Genotyping Direct qPCR master mixes not only simplify the workflow while ensuring superior cluster resolution and allelic discrimination but are also compatible with lyophilization. We will demonstrate how these chemistries enable the detection of SNPs directly from blood, plasma, urine, stool or FFPE tissue, without obligatory nucleic acid extraction and purification and down to 1 copy per reaction. Meridian’s latest development brings faster genotyping testing from high-throughput to point-of-care.